These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22434616)

  • 21. Short-term effects of a multi-disciplinary cardiac rehabilitation programme on psychological well-being, exercise capacity and weight in a sample of obese in-patients with coronary heart disease: a practice-level study.
    Manzoni GM; Villa V; Compare A; Castelnuovo G; Nibbio F; Titon AM; Molinari E; Gondoni LA
    Psychol Health Med; 2011 Mar; 16(2):178-89. PubMed ID: 21328146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
    Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
    Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics.
    Telles R; Lanna C; Ferreira G; Ribeiro A
    Lupus; 2010 Jun; 19(7):803-9. PubMed ID: 20118159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
    Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
    J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the Helsinki Heart Study.
    Koskinen HL; Kauppinen T; Tenkanen L
    Occup Environ Med; 2011 Sep; 68(9):666-73. PubMed ID: 21148595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal obesity explains the positive rural-urban gradient in the prevalence of the metabolic syndrome in Benin, West Africa.
    Ntandou G; Delisle H; Agueh V; Fayomi B
    Nutr Res; 2009 Mar; 29(3):180-9. PubMed ID: 19358932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in cardiac rehabilitation.
    O'Farrell P; Murray J; Huston P; LeGrand C; Adamo K
    Can J Cardiol; 2000 Mar; 16(3):319-25. PubMed ID: 10744794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do the prevalence and components of metabolic syndrome differ among different ethnic groups? A cross-sectional study among obese Malaysian adolescents.
    Narayanan P; Meng OL; Mahanim O
    Metab Syndr Relat Disord; 2011 Oct; 9(5):389-95. PubMed ID: 21718129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians.
    Pei D; Kuo SW; Wu DA; Lin TY; Hseih MC; Lee CH; Hsu WL; Chen SP; Sheu WH; Li JC
    Int J Clin Pract; 2005 Dec; 59(12):1408-16. PubMed ID: 16351672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential benefits of weight loss in coronary heart disease.
    Ades PA; Savage PD
    Prog Cardiovasc Dis; 2014; 56(4):448-56. PubMed ID: 24438737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a lifestyle therapy program using cardiac rehabilitation resources on metabolic syndrome components.
    Rodriguez-Escudero JP; Somers VK; Heath AL; Thomas RJ; Squires RW; Sochor O; Lopez-Jimenez F
    J Cardiopulm Rehabil Prev; 2013; 33(6):360-70. PubMed ID: 24104406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and associated factors of cardio-metabolic risk factors in Iranian seafarers.
    Baygi F; Jensen OC; Qorbani M; Farshad A; Salehi SA; Mohammadi-Nasrabadi F; Asayesh H; Shidfar F
    Int Marit Health; 2016; 67(2):59-65. PubMed ID: 27364169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.